Position in URGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,842,835
-$3,099,292 QoQ
Shares Held
158,111
-46.9% QoQ
Ownership
0.325%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Schonfeld Strategic Advisors LLC holds $295,904,773 across 126 Biotechnology names. URGN ranks #30 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,757,899 | $25,419,219 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
71,767 | $23,745,547 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
318,405 | $21,692,932 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
324,722 | $18,882,584 | |
| 5 | INBX |
Inhibrx Biosciences, Inc.
|
254,827 | $17,132,019 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
62,142 | $11,747,945 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
494,737 | $10,364,740 | |
| 8 | INSM |
INSMED Inc
|
56,056 | $9,166,277 |
All Filings in URGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,842,835 | 158,111 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $5,942,127 | 297,851 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,993,450 | 218,500 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $771,866 | 69,789 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $725,265 | 68,100 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,578,610 | 124,300 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,168,135 | 248,399 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,561,500 | 104,100 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,978,500 | 131,900 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,824,102 | 130,200 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||